Kensington Investment Counsel’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Kensington Investment Counsel's RGEN Position: Q1 2026 in Review
Kensington Investment Counsel reduced its Repligen (RGEN) stake by 60% in Q1 2026, selling an estimated $438K and leaving 2,107 shares worth $248K. The position accounts for 0.12% of the portfolio, ranked #82.
Kensington Investment Counsel first reported a position in RGEN in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.28M in Q4 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Kensington Investment Counsel held 2,107 shares of Repligen worth $248K as of Q1 2026.
- Kensington Investment Counsel sold 3,134 Repligen shares in Q1 2026, an estimated $438K.
- Repligen made up 0.12% of Kensington Investment Counsel's portfolio in Q1 2026, its #82 holding.
- Kensington Investment Counsel first reported a position in Repligen in Q4 2020 and has held it in 21 quarters since.
- Kensington Investment Counsel's Repligen position peaked at $2.28M in Q4 2021.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.